NCOG-48. A PROSPECTIVE LONGITUDINAL NEUROCOGNITIVE OUTCOME STUDY IN PATIENTS TREATED WITH CAR-T-CELL THERAPY AT 6 MONTHS Article Swipe

PDF

Giuliana Zarrella , Mitchell W. Lavoie , Melissa M Gardner , P. Connor Johnson , Areej El‐Jawahri , Michael W. Parsons ·

YOU? · · 2022 · Open Access · · DOI: https://doi.org/10.1093/neuonc/noac209.799

INTRODUCTION Chimeric Antigen Receptor T-cell (CAR-T) therapy carries risk of significant neurocognitive function (NCF) toxicities. Longer term NCF outcomes have yet to be reported. The goal of the current study was to assess NCF prospectively in patients undergoing CAR-T. METHODS Adult patients undergoing CAR-T participated in NCF testing with a cognitive clinical trial battery (CTB) at baseline and 6 months after treatment. Group change on each test and on the composite score (CTBC) was examined with paired t-tests and individual change, defined as +/-1 SD on CTBC, was also reported. RESULTS Forty patients (Mage=62.45, 63% male, 97% Non-Hispanic or Latino) completed NCF testing at baseline, and 28 patients completed NCF measures 6 months post-CAR-T (20 complete CTBC, 8 partial CTB, completed virtually). At baseline, 13/40 patients (33%) had significant impairment in NCF (CTBC Z-score < -1.5), and 2/20 (10%) were impaired at follow-up. In the 20 individuals with pre- and 6-month post-CAR-T CTBC scores, there was no significant change (t(19)=-0.926; p=0.366). Examination of each individual test score also showed no changes (immediate memory (t(26)=-0.084; p=0.934), delayed memory (t(26)=-0.207; p=0.837), memory recognition (t (26)=-0.062; p=0.951) executive function (t(18)=-0.447, p=0.660), and verbal fluency (t(27)=-0.035, p=0.972)). Individual analyses of CTBC at follow-up found the number of patients with meaningful decline=1 (5%), improvement=2 (10%), and no change=17 (85%) on CTBC. CONCLUSION Although CAR-T can be associated with acute change in NCF, this prospective longitudinal study showed stable cognitive performance 6 months after treatment. To our knowledge, this is the longest prospective longitudinal study of NCF in CAR-T survivors. This study is limited in that some subjects completed NCF testing virtually at follow-up, limiting the sample size for unconfounded comparison of performance. Future work will examine longer term outcomes and subjective cognitive function in CAR-T survivors.

Related Topics

Concepts

Medicine Neurocognitive Internal medicine Verbal fluency test Neuropsychology Cognition Psychiatry

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1093/neuonc/noac209.799
PDF: https://academic.oup.com/neuro-oncology/article-pdf/24/Supplement_7/vii208/47020974/noac209.799.pdf
OA Status: bronze
Cited By: 1
Related Works: 10
OpenAlex ID: https://openalex.org/W4309016951

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4309016951

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1093/neuonc/noac209.799

Digital Object Identifier
Title: NCOG-48. A PROSPECTIVE LONGITUDINAL NEUROCOGNITIVE OUTCOME STUDY IN PATIENTS TREATED WITH CAR-T-CELL THERAPY AT 6 MONTHS

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2022

Year of publication
Publication date: 2022-11-01

Full publication date if available
Authors: Giuliana Zarrella, Mitchell W. Lavoie, Melissa M Gardner, P. Connor Johnson, Areej El‐Jawahri, Michael W. Parsons

List of authors in order
Landing page: https://doi.org/10.1093/neuonc/noac209.799

Publisher landing page
PDF URL: https://academic.oup.com/neuro-oncology/article-pdf/24/Supplement_7/vii208/47020974/noac209.799.pdf

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: bronze

Open access status per OpenAlex
OA URL: https://academic.oup.com/neuro-oncology/article-pdf/24/Supplement_7/vii208/47020974/noac209.799.pdf

Direct OA link when available
Concepts: Medicine, Neurocognitive, Internal medicine, Verbal fluency test, Neuropsychology, Cognition, Psychiatry

Top concepts (fields/topics) attached by OpenAlex
Cited by: 1

Total citation count in OpenAlex
Citations by year (recent): 2024: 1

Per-year citation counts (last 5 years)
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4309016951
doi	https://doi.org/10.1093/neuonc/noac209.799
ids.doi	https://doi.org/10.1093/neuonc/noac209.799
ids.openalex	https://openalex.org/W4309016951
fwci	0.20489849
type	article
title	NCOG-48. A PROSPECTIVE LONGITUDINAL NEUROCOGNITIVE OUTCOME STUDY IN PATIENTS TREATED WITH CAR-T-CELL THERAPY AT 6 MONTHS
biblio.issue	Supplement_7
biblio.volume	24
biblio.last_page	vii208
biblio.first_page	vii208
topics[0].id	https://openalex.org/T13077
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.741599977016449
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2740
topics[0].subfield.display_name	Pulmonary and Respiratory Medicine
topics[0].display_name	Cancer-related cognitive impairment studies
topics[1].id	https://openalex.org/T11601
topics[1].field.id	https://openalex.org/fields/28
topics[1].field.display_name	Neuroscience
topics[1].score	0.715399980545044
topics[1].domain.id	https://openalex.org/domains/1
topics[1].domain.display_name	Life Sciences
topics[1].subfield.id	https://openalex.org/subfields/2804
topics[1].subfield.display_name	Cellular and Molecular Neuroscience
topics[1].display_name	Neuroscience and Neural Engineering
topics[2].id	https://openalex.org/T12859
topics[2].field.id	https://openalex.org/fields/13
topics[2].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[2].score	0.6525999903678894
topics[2].domain.id	https://openalex.org/domains/1
topics[2].domain.display_name	Life Sciences
topics[2].subfield.id	https://openalex.org/subfields/1304
topics[2].subfield.display_name	Biophysics
topics[2].display_name	Cell Image Analysis Techniques
is_xpac	False
apc_list.value	4612
apc_list.currency	USD
apc_list.value_usd	4612
apc_paid
concepts[0].id	https://openalex.org/C71924100
concepts[0].level	0
concepts[0].score	0.7419123649597168
concepts[0].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[0].display_name	Medicine
concepts[1].id	https://openalex.org/C172467417
concepts[1].level	3
concepts[1].score	0.6838616728782654
concepts[1].wikidata	https://www.wikidata.org/wiki/Q1670397
concepts[1].display_name	Neurocognitive
concepts[2].id	https://openalex.org/C126322002
concepts[2].level	1
concepts[2].score	0.5370157957077026
concepts[2].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[2].display_name	Internal medicine
concepts[3].id	https://openalex.org/C97530452
concepts[3].level	4
concepts[3].score	0.4884470999240875
concepts[3].wikidata	https://www.wikidata.org/wiki/Q7920939
concepts[3].display_name	Verbal fluency test
concepts[4].id	https://openalex.org/C14216870
concepts[4].level	3
concepts[4].score	0.29704880714416504
concepts[4].wikidata	https://www.wikidata.org/wiki/Q3872
concepts[4].display_name	Neuropsychology
concepts[5].id	https://openalex.org/C169900460
concepts[5].level	2
concepts[5].score	0.26118773221969604
concepts[5].wikidata	https://www.wikidata.org/wiki/Q2200417
concepts[5].display_name	Cognition
concepts[6].id	https://openalex.org/C118552586
concepts[6].level	1
concepts[6].score	0.1433030068874359
concepts[6].wikidata	https://www.wikidata.org/wiki/Q7867
concepts[6].display_name	Psychiatry
keywords[0].id	https://openalex.org/keywords/medicine
keywords[0].score	0.7419123649597168
keywords[0].display_name	Medicine
keywords[1].id	https://openalex.org/keywords/neurocognitive
keywords[1].score	0.6838616728782654
keywords[1].display_name	Neurocognitive
keywords[2].id	https://openalex.org/keywords/internal-medicine
keywords[2].score	0.5370157957077026
keywords[2].display_name	Internal medicine
keywords[3].id	https://openalex.org/keywords/verbal-fluency-test
keywords[3].score	0.4884470999240875
keywords[3].display_name	Verbal fluency test
keywords[4].id	https://openalex.org/keywords/neuropsychology
keywords[4].score	0.29704880714416504
keywords[4].display_name	Neuropsychology
keywords[5].id	https://openalex.org/keywords/cognition
keywords[5].score	0.26118773221969604
keywords[5].display_name	Cognition
keywords[6].id	https://openalex.org/keywords/psychiatry
keywords[6].score	0.1433030068874359
keywords[6].display_name	Psychiatry
language	en
locations[0].id	doi:10.1093/neuonc/noac209.799
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S106908163
locations[0].source.issn	1522-8517, 1523-5866
locations[0].source.type	journal
locations[0].source.is_oa	False
locations[0].source.issn_l	1522-8517
locations[0].source.is_core	True
locations[0].source.is_in_doaj	False
locations[0].source.display_name	Neuro-Oncology
locations[0].source.host_organization	https://openalex.org/P4310311648
locations[0].source.host_organization_name	Oxford University Press
locations[0].source.host_organization_lineage	https://openalex.org/P4310311648
locations[0].license
locations[0].pdf_url	https://academic.oup.com/neuro-oncology/article-pdf/24/Supplement_7/vii208/47020974/noac209.799.pdf
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	Neuro-Oncology
locations[0].landing_page_url	https://doi.org/10.1093/neuonc/noac209.799
locations[1].id	pmh:oai:pubmedcentral.nih.gov:9660790
locations[1].is_oa	True
locations[1].source.id	https://openalex.org/S2764455111
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	PubMed Central
locations[1].source.host_organization	https://openalex.org/I1299303238
locations[1].source.host_organization_name	National Institutes of Health
locations[1].source.host_organization_lineage	https://openalex.org/I1299303238
locations[1].license
locations[1].pdf_url
locations[1].version	submittedVersion
locations[1].raw_type	Text
locations[1].license_id
locations[1].is_accepted	False
locations[1].is_published	False
locations[1].raw_source_name	Neuro Oncol
locations[1].landing_page_url	https://www.ncbi.nlm.nih.gov/pmc/articles/9660790
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5010574484
authorships[0].author.orcid	https://orcid.org/0009-0009-4816-231X
authorships[0].author.display_name	Giuliana Zarrella
authorships[0].countries	US
authorships[0].affiliations[0].institution_ids	https://openalex.org/I136199984, https://openalex.org/I4210087915
authorships[0].affiliations[0].raw_affiliation_string	Psychology Assessment Center, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School , Boston, MA , USA
authorships[0].institutions[0].id	https://openalex.org/I136199984
authorships[0].institutions[0].ror	https://ror.org/03vek6s52
authorships[0].institutions[0].type	education
authorships[0].institutions[0].lineage	https://openalex.org/I136199984
authorships[0].institutions[0].country_code	US
authorships[0].institutions[0].display_name	Harvard University
authorships[0].institutions[1].id	https://openalex.org/I4210087915
authorships[0].institutions[1].ror	https://ror.org/002pd6e78
authorships[0].institutions[1].type	healthcare
authorships[0].institutions[1].lineage	https://openalex.org/I4210087915, https://openalex.org/I48633490
authorships[0].institutions[1].country_code	US
authorships[0].institutions[1].display_name	Massachusetts General Hospital
authorships[0].author_position	first
authorships[0].raw_author_name	Giuliana Zarrella
authorships[0].is_corresponding	False
authorships[0].raw_affiliation_strings	Psychology Assessment Center, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School , Boston, MA , USA
authorships[1].author.id	https://openalex.org/A5084270400
authorships[1].author.orcid	https://orcid.org/0000-0003-0493-5703
authorships[1].author.display_name	Mitchell W. Lavoie
authorships[1].countries	US
authorships[1].affiliations[0].institution_ids	https://openalex.org/I136199984, https://openalex.org/I4210087915
authorships[1].affiliations[0].raw_affiliation_string	Cancer Outcomes Research & Education Program, MGH Cancer Center, Massachusetts General Hospital and Harvard Medical School , Boston, MA , USA
authorships[1].institutions[0].id	https://openalex.org/I136199984
authorships[1].institutions[0].ror	https://ror.org/03vek6s52
authorships[1].institutions[0].type	education
authorships[1].institutions[0].lineage	https://openalex.org/I136199984
authorships[1].institutions[0].country_code	US
authorships[1].institutions[0].display_name	Harvard University
authorships[1].institutions[1].id	https://openalex.org/I4210087915
authorships[1].institutions[1].ror	https://ror.org/002pd6e78
authorships[1].institutions[1].type	healthcare
authorships[1].institutions[1].lineage	https://openalex.org/I4210087915, https://openalex.org/I48633490
authorships[1].institutions[1].country_code	US
authorships[1].institutions[1].display_name	Massachusetts General Hospital
authorships[1].author_position	middle
authorships[1].raw_author_name	Mitchell Lavoie
authorships[1].is_corresponding	False
authorships[1].raw_affiliation_strings	Cancer Outcomes Research & Education Program, MGH Cancer Center, Massachusetts General Hospital and Harvard Medical School , Boston, MA , USA
authorships[2].author.id	https://openalex.org/A5044519961
authorships[2].author.orcid	https://orcid.org/0000-0002-8012-5991
authorships[2].author.display_name	Melissa M Gardner
authorships[2].countries	US
authorships[2].affiliations[0].institution_ids	https://openalex.org/I136199984, https://openalex.org/I4210087915
authorships[2].affiliations[0].raw_affiliation_string	Division of Neuro-Oncology, MGH Cancer Center, Massachusetts General Hospital and Harvard Medical School , Boston, MA , USA
authorships[2].institutions[0].id	https://openalex.org/I136199984
authorships[2].institutions[0].ror	https://ror.org/03vek6s52
authorships[2].institutions[0].type	education
authorships[2].institutions[0].lineage	https://openalex.org/I136199984
authorships[2].institutions[0].country_code	US
authorships[2].institutions[0].display_name	Harvard University
authorships[2].institutions[1].id	https://openalex.org/I4210087915
authorships[2].institutions[1].ror	https://ror.org/002pd6e78
authorships[2].institutions[1].type	healthcare
authorships[2].institutions[1].lineage	https://openalex.org/I4210087915, https://openalex.org/I48633490
authorships[2].institutions[1].country_code	US
authorships[2].institutions[1].display_name	Massachusetts General Hospital
authorships[2].author_position	middle
authorships[2].raw_author_name	Melissa Gardner
authorships[2].is_corresponding	False
authorships[2].raw_affiliation_strings	Division of Neuro-Oncology, MGH Cancer Center, Massachusetts General Hospital and Harvard Medical School , Boston, MA , USA
authorships[3].author.id	https://openalex.org/A5080912052
authorships[3].author.orcid	https://orcid.org/0000-0002-3943-6608
authorships[3].author.display_name	P. Connor Johnson
authorships[3].countries	US
authorships[3].affiliations[0].institution_ids	https://openalex.org/I136199984, https://openalex.org/I4210087915
authorships[3].affiliations[0].raw_affiliation_string	Division of Hematology Oncology, MGH Cancer Center, Massachusetts General Hospital and Harvard Medical School , Boston, MA , USA
authorships[3].institutions[0].id	https://openalex.org/I136199984
authorships[3].institutions[0].ror	https://ror.org/03vek6s52
authorships[3].institutions[0].type	education
authorships[3].institutions[0].lineage	https://openalex.org/I136199984
authorships[3].institutions[0].country_code	US
authorships[3].institutions[0].display_name	Harvard University
authorships[3].institutions[1].id	https://openalex.org/I4210087915
authorships[3].institutions[1].ror	https://ror.org/002pd6e78
authorships[3].institutions[1].type	healthcare
authorships[3].institutions[1].lineage	https://openalex.org/I4210087915, https://openalex.org/I48633490
authorships[3].institutions[1].country_code	US
authorships[3].institutions[1].display_name	Massachusetts General Hospital
authorships[3].author_position	middle
authorships[3].raw_author_name	Patrick Johnson
authorships[3].is_corresponding	False
authorships[3].raw_affiliation_strings	Division of Hematology Oncology, MGH Cancer Center, Massachusetts General Hospital and Harvard Medical School , Boston, MA , USA
authorships[4].author.id	https://openalex.org/A5078852708
authorships[4].author.orcid	https://orcid.org/0000-0002-3556-1495
authorships[4].author.display_name	Areej El‐Jawahri
authorships[4].countries	US
authorships[4].affiliations[0].institution_ids	https://openalex.org/I136199984, https://openalex.org/I4210087915
authorships[4].affiliations[0].raw_affiliation_string	Bone Marrow Transplant Program, MGH Cancer Center, Massachusetts General Hospital and Harvard Medical School , Boston, MA , USA
authorships[4].institutions[0].id	https://openalex.org/I136199984
authorships[4].institutions[0].ror	https://ror.org/03vek6s52
authorships[4].institutions[0].type	education
authorships[4].institutions[0].lineage	https://openalex.org/I136199984
authorships[4].institutions[0].country_code	US
authorships[4].institutions[0].display_name	Harvard University
authorships[4].institutions[1].id	https://openalex.org/I4210087915
authorships[4].institutions[1].ror	https://ror.org/002pd6e78
authorships[4].institutions[1].type	healthcare
authorships[4].institutions[1].lineage	https://openalex.org/I4210087915, https://openalex.org/I48633490
authorships[4].institutions[1].country_code	US
authorships[4].institutions[1].display_name	Massachusetts General Hospital
authorships[4].author_position	middle
authorships[4].raw_author_name	Areej El-Jawahri
authorships[4].is_corresponding	False
authorships[4].raw_affiliation_strings	Bone Marrow Transplant Program, MGH Cancer Center, Massachusetts General Hospital and Harvard Medical School , Boston, MA , USA
authorships[5].author.id	https://openalex.org/A5020641478
authorships[5].author.orcid	https://orcid.org/0000-0001-8619-9564
authorships[5].author.display_name	Michael W. Parsons
authorships[5].countries	US
authorships[5].affiliations[0].institution_ids	https://openalex.org/I136199984, https://openalex.org/I4210087915
authorships[5].affiliations[0].raw_affiliation_string	Division of Neuro-Oncology, MGH Cancer Center, Massachusetts General Hospital and Harvard Medical School , Boston, MA , USA
authorships[5].institutions[0].id	https://openalex.org/I136199984
authorships[5].institutions[0].ror	https://ror.org/03vek6s52
authorships[5].institutions[0].type	education
authorships[5].institutions[0].lineage	https://openalex.org/I136199984
authorships[5].institutions[0].country_code	US
authorships[5].institutions[0].display_name	Harvard University
authorships[5].institutions[1].id	https://openalex.org/I4210087915
authorships[5].institutions[1].ror	https://ror.org/002pd6e78
authorships[5].institutions[1].type	healthcare
authorships[5].institutions[1].lineage	https://openalex.org/I4210087915, https://openalex.org/I48633490
authorships[5].institutions[1].country_code	US
authorships[5].institutions[1].display_name	Massachusetts General Hospital
authorships[5].author_position	last
authorships[5].raw_author_name	Michael Parsons
authorships[5].is_corresponding	False
authorships[5].raw_affiliation_strings	Division of Neuro-Oncology, MGH Cancer Center, Massachusetts General Hospital and Harvard Medical School , Boston, MA , USA
has_content.pdf	True
has_content.grobid_xml	True
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://academic.oup.com/neuro-oncology/article-pdf/24/Supplement_7/vii208/47020974/noac209.799.pdf
open_access.oa_status	bronze
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	NCOG-48. A PROSPECTIVE LONGITUDINAL NEUROCOGNITIVE OUTCOME STUDY IN PATIENTS TREATED WITH CAR-T-CELL THERAPY AT 6 MONTHS
has_fulltext	True
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T13077
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.741599977016449
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2740
primary_topic.subfield.display_name	Pulmonary and Respiratory Medicine
primary_topic.display_name	Cancer-related cognitive impairment studies
related_works	https://openalex.org/W567737511, https://openalex.org/W1833709397, https://openalex.org/W2141857071, https://openalex.org/W2094785745, https://openalex.org/W2069418962, https://openalex.org/W2014882001, https://openalex.org/W3094364480, https://openalex.org/W2178793905, https://openalex.org/W2130760039, https://openalex.org/W3134039390
cited_by_count	1
counts_by_year[0].year	2024
counts_by_year[0].cited_by_count	1
locations_count	2
best_oa_location.id	doi:10.1093/neuonc/noac209.799
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S106908163
best_oa_location.source.issn	1522-8517, 1523-5866
best_oa_location.source.type	journal
best_oa_location.source.is_oa	False
best_oa_location.source.issn_l	1522-8517
best_oa_location.source.is_core	True
best_oa_location.source.is_in_doaj	False
best_oa_location.source.display_name	Neuro-Oncology
best_oa_location.source.host_organization	https://openalex.org/P4310311648
best_oa_location.source.host_organization_name	Oxford University Press
best_oa_location.source.host_organization_lineage	https://openalex.org/P4310311648
best_oa_location.license
best_oa_location.pdf_url	https://academic.oup.com/neuro-oncology/article-pdf/24/Supplement_7/vii208/47020974/noac209.799.pdf
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	Neuro-Oncology
best_oa_location.landing_page_url	https://doi.org/10.1093/neuonc/noac209.799
primary_location.id	doi:10.1093/neuonc/noac209.799
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S106908163
primary_location.source.issn	1522-8517, 1523-5866
primary_location.source.type	journal
primary_location.source.is_oa	False
primary_location.source.issn_l	1522-8517
primary_location.source.is_core	True
primary_location.source.is_in_doaj	False
primary_location.source.display_name	Neuro-Oncology
primary_location.source.host_organization	https://openalex.org/P4310311648
primary_location.source.host_organization_name	Oxford University Press
primary_location.source.host_organization_lineage	https://openalex.org/P4310311648
primary_location.license
primary_location.pdf_url	https://academic.oup.com/neuro-oncology/article-pdf/24/Supplement_7/vii208/47020974/noac209.799.pdf
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	Neuro-Oncology
primary_location.landing_page_url	https://doi.org/10.1093/neuonc/noac209.799
publication_date	2022-11-01
publication_year	2022
referenced_works_count	0
abstract_inverted_index.6	59, 112, 236
abstract_inverted_index.8	118
abstract_inverted_index.a	50
abstract_inverted_index.(t	182
abstract_inverted_index.20	146
abstract_inverted_index.28	107
abstract_inverted_index.At	123
abstract_inverted_index.In	144
abstract_inverted_index.SD	85
abstract_inverted_index.To	240
abstract_inverted_index.as	83
abstract_inverted_index.at	56, 104, 142, 198, 267
abstract_inverted_index.be	23, 221
abstract_inverted_index.in	36, 46, 131, 226, 252, 259, 289
abstract_inverted_index.is	244, 257
abstract_inverted_index.no	157, 170, 212
abstract_inverted_index.of	10, 27, 163, 196, 203, 250, 276
abstract_inverted_index.on	65, 69, 86, 215
abstract_inverted_index.or	99
abstract_inverted_index.to	22, 32
abstract_inverted_index.(20	115
abstract_inverted_index.63%	95
abstract_inverted_index.97%	97
abstract_inverted_index.NCF	18, 34, 47, 102, 110, 132, 251, 264
abstract_inverted_index.The	25
abstract_inverted_index.and	58, 68, 79, 106, 137, 150, 189, 211, 285
abstract_inverted_index.can	220
abstract_inverted_index.for	273
abstract_inverted_index.had	128
abstract_inverted_index.our	241
abstract_inverted_index.the	28, 70, 145, 201, 245, 270
abstract_inverted_index.was	31, 74, 88, 156
abstract_inverted_index.yet	21
abstract_inverted_index.+/-1	84
abstract_inverted_index.2/20	138
abstract_inverted_index.CTB,	120
abstract_inverted_index.CTBC	153, 197
abstract_inverted_index.NCF,	227
abstract_inverted_index.This	255
abstract_inverted_index.also	89, 168
abstract_inverted_index.each	66, 164
abstract_inverted_index.goal	26
abstract_inverted_index.have	20
abstract_inverted_index.pre-	149
abstract_inverted_index.risk	9
abstract_inverted_index.size	272
abstract_inverted_index.some	261
abstract_inverted_index.term	17, 283
abstract_inverted_index.test	67, 166
abstract_inverted_index.that	260
abstract_inverted_index.this	228, 243
abstract_inverted_index.were	140
abstract_inverted_index.will	280
abstract_inverted_index.with	49, 76, 148, 205, 223
abstract_inverted_index.work	279
abstract_inverted_index.(10%)	139
abstract_inverted_index.(33%)	127
abstract_inverted_index.(5%),	208
abstract_inverted_index.(85%)	214
abstract_inverted_index.(CTB)	55
abstract_inverted_index.(CTBC	133
abstract_inverted_index.(NCF)	14
abstract_inverted_index.13/40	125
abstract_inverted_index.Adult	41
abstract_inverted_index.CAR-T	44, 219, 253, 290
abstract_inverted_index.CTBC,	87, 117
abstract_inverted_index.CTBC.	216
abstract_inverted_index.Forty	92
abstract_inverted_index.Group	63
abstract_inverted_index.acute	224
abstract_inverted_index.after	61, 238
abstract_inverted_index.found	200
abstract_inverted_index.male,	96
abstract_inverted_index.score	72, 167
abstract_inverted_index.study	30, 231, 249, 256
abstract_inverted_index.there	155
abstract_inverted_index.trial	53
abstract_inverted_index.(10%),	210
abstract_inverted_index.(CTBC)	73
abstract_inverted_index.-1.5),	136
abstract_inverted_index.CAR-T.	39
abstract_inverted_index.Future	278
abstract_inverted_index.Longer	16
abstract_inverted_index.T-cell	5
abstract_inverted_index.assess	33
abstract_inverted_index.change	64, 159, 225
abstract_inverted_index.longer	282
abstract_inverted_index.memory	173, 177, 180
abstract_inverted_index.months	60, 113, 237
abstract_inverted_index.number	202
abstract_inverted_index.paired	77
abstract_inverted_index.sample	271
abstract_inverted_index.showed	169, 232
abstract_inverted_index.stable	233
abstract_inverted_index.verbal	190
abstract_inverted_index.(CAR-T)	6
abstract_inverted_index.6-month	151
abstract_inverted_index.Antigen	3
abstract_inverted_index.Latino)	100
abstract_inverted_index.METHODS	40
abstract_inverted_index.RESULTS	91
abstract_inverted_index.Z-score	134
abstract_inverted_index.battery	54
abstract_inverted_index.carries	8
abstract_inverted_index.change,	81
abstract_inverted_index.changes	171
abstract_inverted_index.current	29
abstract_inverted_index.defined	82
abstract_inverted_index.delayed	176
abstract_inverted_index.examine	281
abstract_inverted_index.fluency	191
abstract_inverted_index.limited	258
abstract_inverted_index.longest	246
abstract_inverted_index.partial	119
abstract_inverted_index.scores,	154
abstract_inverted_index.t-tests	78
abstract_inverted_index.testing	48, 103, 265
abstract_inverted_index.therapy	7
abstract_inverted_index.&lt;	135
abstract_inverted_index.Abstract	0
abstract_inverted_index.Although	218
abstract_inverted_index.Chimeric	2
abstract_inverted_index.Receptor	4
abstract_inverted_index.analyses	195
abstract_inverted_index.baseline	57
abstract_inverted_index.clinical	52
abstract_inverted_index.complete	116
abstract_inverted_index.examined	75
abstract_inverted_index.function	13, 186, 288
abstract_inverted_index.impaired	141
abstract_inverted_index.limiting	269
abstract_inverted_index.measures	111
abstract_inverted_index.outcomes	19, 284
abstract_inverted_index.p=0.951)	184
abstract_inverted_index.patients	37, 42, 93, 108, 126, 204
abstract_inverted_index.subjects	262
abstract_inverted_index.baseline,	105, 124
abstract_inverted_index.change=17	213
abstract_inverted_index.cognitive	51, 234, 287
abstract_inverted_index.completed	101, 109, 121, 263
abstract_inverted_index.composite	71
abstract_inverted_index.decline=1	207
abstract_inverted_index.executive	185
abstract_inverted_index.follow-up	199
abstract_inverted_index.p=0.366).	161
abstract_inverted_index.p=0.660),	188
abstract_inverted_index.p=0.837),	179
abstract_inverted_index.p=0.934),	175
abstract_inverted_index.reported.	24, 90
abstract_inverted_index.virtually	266
abstract_inverted_index.(immediate	172
abstract_inverted_index.CONCLUSION	217
abstract_inverted_index.Individual	194
abstract_inverted_index.associated	222
abstract_inverted_index.comparison	275
abstract_inverted_index.follow-up,	268
abstract_inverted_index.follow-up.	143
abstract_inverted_index.impairment	130
abstract_inverted_index.individual	80, 165
abstract_inverted_index.knowledge,	242
abstract_inverted_index.meaningful	206
abstract_inverted_index.p=0.972)).	193
abstract_inverted_index.post-CAR-T	114, 152
abstract_inverted_index.subjective	286
abstract_inverted_index.survivors.	254, 291
abstract_inverted_index.treatment.	62, 239
abstract_inverted_index.undergoing	38, 43
abstract_inverted_index.Examination	162
abstract_inverted_index.individuals	147
abstract_inverted_index.performance	235
abstract_inverted_index.prospective	229, 247
abstract_inverted_index.recognition	181
abstract_inverted_index.significant	11, 129, 158
abstract_inverted_index.toxicities.	15
abstract_inverted_index.virtually).	122
abstract_inverted_index.(26)=-0.062;	183
abstract_inverted_index.(Mage=62.45,	94
abstract_inverted_index.INTRODUCTION	1
abstract_inverted_index.Non-Hispanic	98
abstract_inverted_index.longitudinal	230, 248
abstract_inverted_index.participated	45
abstract_inverted_index.performance.	277
abstract_inverted_index.unconfounded	274
abstract_inverted_index.improvement=2	209
abstract_inverted_index.prospectively	35
abstract_inverted_index.(t(18)=-0.447,	187
abstract_inverted_index.(t(19)=-0.926;	160
abstract_inverted_index.(t(26)=-0.084;	174
abstract_inverted_index.(t(26)=-0.207;	178
abstract_inverted_index.(t(27)=-0.035,	192
abstract_inverted_index.neurocognitive	12
cited_by_percentile_year.max	94
cited_by_percentile_year.min	90
countries_distinct_count	1
institutions_distinct_count	6
sustainable_development_goals[0].id	https://metadata.un.org/sdg/4
sustainable_development_goals[0].score	0.7599999904632568
sustainable_development_goals[0].display_name	Quality Education
citation_normalized_percentile.value	0.53808492
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False